Metraipolis › archive › dc_c045e65a8002

Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children — Europe PMC PMID:42104335

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42104335
DOI
10.1186/s12887-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-02T14:40:36.641Z
SHA-256 of the archived text
eda2a2362884e6098eedd6e9b8970c58a1a7c03af56d432aef7079920cc9fc0c
Stable URL of this page
https://metraipolis.com/documento/dc_c045e65a8002

How to cite

Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children — Europe PMC PMID:42104335 — Europe PMC (en), https://europepmc.org/article/MED/42104335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c045e65a8002 (Metraipolis archive dc_c045e65a8002, sha256 eda2a2362884e6098eedd6e9b8970c58a1a7c03af56d432aef7079920cc9fc0c)
BibTeX
@misc{dcc045e65a8002,
  title = {Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children — Europe PMC PMID:42104335},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42104335},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c045e65a8002; sha256 eda2a2362884e6098eedd6e9b8970c58a1a7c03af56d432aef7079920cc9fc0c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42104335. Agents can read the archived copy with the MCP tool read_document.